1. Shell lost US$5bn last quarter on Russia withdrawal
In February, Shell exited three joint ventures with Gazprom following Russia's invasion of Ukraine.
The write-down of receivables, expected credit losses, and onerous contracts relating to its Russia activities are expected to lead to US$4bn-US$5bn of charges, investors were told.
2. AstraZeneca develops two antibody-drug conjugate (ADC) cancer treatments
ADCs combine antibodies with therapeutic payloads, that can then accurately target diseases such as cancer without the collateral damage that comes with some traditional therapies.
3. Nuclear, offshore wind and revitalised North Sea at centre of Britain’s energy future
In a wide-ranging document, the PM said the new National Energy Strategy would reduce "dependence on power sources exposed to volatile international prices we cannot control".
A new nuclear power body, Great British Nuclear, will be set up immediately to look into new projects backed by state money, Johnson said, while a £120mln Future Nuclear Enabling Fund will launch later this month.
4. North Sea Harbour and Serica named ‘top brands’ by American bank Jeffries
Driven by significantly higher oil and gas prices, and heightened demand for new sources of fuel, Jefferies has redrawn its preferred stocks in the sector.
5. FTSE 100
London's FTSE 100 ended trade 36 points, or 0.47% lower at 7,552, weighed down by a swathe of ex-dividend stocks and the hawkish tone struck by the US Federal Reserve in the minutes of its most recent meeting.